Abstract
White matter hyperintensities (WMH) are common neuroimaging findings in brain scans of elderly people. WMH lead to structural and functional changes in brain connectivity and impact cognitive function. Using 7T MRI, we examined 40 cognitively healthy subjects (16 females, mean age 69.3) with WMH presence, clustered into three groups of low, moderate, and high WMH burden. We used diffusion tensor imaging data to construct structural connectivity matrices and resting-state functional MRI data to construct functional connectivity matrices. Using network-based statistics (NBS) and graph-theory analysis (GTA), we compared the structural and functional network differences between the groups and their association to cognitive function. NBS analysis revealed altered structural connectivity strength in the default mode network (DMN) in the high WMH burden group, which correlated with the Trail Making Test scores. GTA revealed, that compared to the low burden, the high burden group had increased small-worldness and modularity in the structural connectivity, and increased assortativity in the functional connectivity. We found altered betweenness centrality (BC) in the DMN on both structural and functional connectivity. The BC difference in the functional connectivity in the DMN between the high and the low WMH burden groups had a linear relationship with Montreal Cognitive Assessment scores. Our results demonstrate that WMH burden alters both structural and functional brain connectivity and affects large-scale network organization at local and global levels in an otherwise healthy elderly population.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT05086055
Funding Statement
This study was funded by The Research Council of Norway PROTEQT Grant number 302523 and Samarbeidsorganet Helse Midt-Norge HMN NTNU Clinical Academic Group for Alzheimers disease Grant number 5981.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Regional Ethical Committee of Central Norway (Regionale komiteer for medisinsk og helsefaglig forskningsetikk, REK midt) gave ethical approval for this work. (REK Number 171264)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵1 E.A.C and N.D share first authorship.
Clinical Trial Registration Information: The study is registered at clinicaltrials.gov with the Project Identifier: NCT05086055.
Data availability
Raw and processed MRI data that have been used are confidential. Other data will be made available upon reasonable request.
